数据继续证明，与靶向抗癌药Sutent（索坦，通用名：sunitinib，舒尼替尼）相比，Opdivo+Yervoy免疫组合疗法（OY组合）一线治疗具有长期的生存受益和 ...

在7月27日的Cell杂志上，耶鲁医学院的研究人员描述的一种与癌症有关的高分辨率的受体分子图像为研发新一代抗癌药物提供了 ...

Sutent (sunitinib) is a brand-name oral capsule that’s prescribed for certain types of cancers in adults. As with other drugs, Sutent can cause side effects, such as fatigue, diarrhea ...

Sutent (sunitinib) is a prescription drug used to treat renal cell carcinoma and certain other types of cancer. Sutent can cause side effects that range from mild to serious. Examples include ...

At the end of the 1990s SUGEN was taken over by Pharmacia, which itself was bought by Pfizer in 2003. Development of the project continued at Pfizer. SUTENT® (active ingredient Sunitinib) has now ...

Sutent (sunitinib malate) is a prescription drug used to treat certain types of cancer. The drug comes as an oral capsule that’s usually taken once per day. is locally advanced (near the ...

Sutent (sunitinib) is a brand-name oral capsule prescribed for certain cancers. Sutent has interactions with some other drugs and certain supplements. Examples include ondansetron, metformin ...

NEW YORK, June 30 (Reuters) - Pfizer Inc said a late stage trial testing its cancer drug Sutent in advanced colon cancer was discontinued after it was deemed to be no more effective than standard ...

Sunitinib (sunitinib malate; SU11248; SUTENT ®; Pfizer Inc., New York, NY, USA) is an orally bioavailable, oxindole, multi-targeted tyrosine kinase inhibitor with antitumour and antiangiogenic ...

Pfizer shares are trading to the downside Monday, despite news that the Food and Drug Administration approved its cancer drug Sutent to treat progressive, well-differentiated pancreatic ...

Bezuclastinib and Sutent combination therapy demonstrated improved PFS in GIST patients, especially those previously treated with Gleevec. The combination therapy targets multiple KIT mutations, ...